Civil Procedure
Oct. 7, 2026
Nevro spinal cord stimulator lawsuits consolidated in Northern District
A federal judicial panel centralized 17 product liability lawsuits alleging Nevro improperly used the FDA's supplemental approval process to introduce modified spinal cord stimulators without adequate regulatory scrutiny or clinical testing.
Seventeen product liability lawsuits alleging injuries from Nevro Corp.'s spinal cord stimulators have been consolidated in the Northern District of California.
The U.S. Judicial Panel on Multidistrict Litigation created the MDL on Friday, finding the cases raise common questions about whether the Redwood City medical device manufacturer improperly used the Food and Drug Administration's supplemental approval process to introduce modified versions of its spinal cord stimul...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In